argenx SE American Depositary Receipt (ARGX)
Market Closed
3 Jun, 20:00
$
813. 14
+10.97
+1.3675%
$
50.78B Market Cap
- P/E Ratio
- Div Yield
301,834 Volume
- Eps
$ 802.17
Previous Close 
Want to track ARGX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
FDA Expands argenx's (ARGX) Vyvgart Label to Treat Rare Disorder
Per argenx (ARGX), the label expansion to Vyvgart Hytrulo makes it the first FDA-approved medication with a novel mechanism of action to treat chronic inflammatory demyelinating polyneuropathy.
Zacks | 1 year ago
Argenx Surges After Its Bread-And-Butter Drug Wins Another FDA Approval
Argenx stock surged Monday after the FDA approved its drug, Vyvgart Hytrulo, for patients with an autoimmune condition known as CIDP.
Investors | 1 year ago
